NIH Awards $3.1M to Study Stomach Cancer Development

Pennsylvania State University

Jason Mills , professor and chair of the Department of Molecular and Precision Medicine at Penn State College of Medicine, has received a $3.1 million award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to investigate how precancerous changes in the stomach develop and potentially progress to cancer.

The research will examine the biological processes involved in gastric intestinal metaplasia, a condition associated with an increased risk of stomach cancer, with the goal of identifying potential ways to prevent or reverse its progression.

Intestinal metaplasia occurs when the lining of the stomach begins to take on characteristics of the intestine. Although researchers do not fully understand why it develops, one theory is that it represents the stomach lining's response to certain types of long-term or recurring injury.

Mills and his team previously developed a genetically modified mouse model that allows them to investigate how intestinal metaplasia emerges and changes over time.

Previously, the team relied on donated human stomach tissue that was preserved to provide a snapshot of the tissue at a single point in time, but it did not allow researchers to follow disease progression or experimentally test what influences it.

With the new mouse model, researchers can investigate how changes in the stomach environment contribute to intestinal metaplasia. One hypothesis is that the loss of acid-producing cells allows potentially harmful bacteria to grow, causing inflammation and injury to the stomach lining. Bile that flows backward from the small intestine into the stomach may contribute to that damage.

The team will test these ideas in mice and use organoids, or three-dimensional models grown from donated human patient tissue, to examine individual components of the process and assess how well the findings reflect human biology. Sarah To, assistant professor of molecular and precision medicine, will contribute to some of the experiments.

The research could also help identify potential approaches to interrupting disease progression, Mills explained. For example, the team plans to investigate whether targeting bacteria associated with intestinal metaplasia, altering bile-related processes or pursuing other strategies could stop or reverse the condition.

"Thus, for example, by treating the bacteria that lead to the metaplasia or changing or blocking the bile involved or by other approaches we don't know yet, we might be able to reverse or stop the metaplasia," said Mills.

Further research will be needed to determine whether any findings can be translated into strategies for preventing stomach cancer in people. However, the researchers said the ability to study the condition over time and test potential interventions could help researchers better understand the mechanisms underlying its development.

Mills explained that the stomach remains an understudied organ despite its role in a wide range of diseases, from heartburn and ulcers to cancer, and he said he hopes the research will also contribute to a better understanding of how factors such as diet and medications may influence the stem cells that maintain the stomach lining.

The project is supported by the National Institutes of Health's National Cancer Institute under award 1R01CA304170-01A1. This content is the sole responsibility of the authors and does not necessarily reflect the views of the funder.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.